Lyell Immunopharma

+$0.74 (+5.12%) Today
$0.00 (0.00%) As of 8:01 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LYEL and other ETFs, options, and stocks.

About LYEL

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D.

CEO
Elizabeth Homans
Employees
—
Headquarters
South San Francisco, California
Founded
2018

LYEL Key Statistics

Market Cap
3.64B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
165.02K
High Today
$15.46
Low Today
$14.33
Open Price
$14.49
Volume
231.70K
52 Week High
$19.84
52 Week Low
$10.62

LYEL Earnings

-$0.89
-$0.59
-$0.30
$0.00
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Oct 28, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure